venerdì, 27 novembre 2020
Medinews
20 Luglio 2018

EU and Japan reinforce their collaboration on inspections of medicine manufacturers

July 18, 2018 – The European Union (EU) and Japan have agreed to broaden the range of medicines for which they will recognise each other’s inspections of manufacturing sites. The current mutual recognition agreement (MRA) between the EU and Japan has been operational since 29 May 2004. It allows regulators to rely on good manufacturing practice (GMP) inspections in each other’s territories, to waive batch testing of medicines that enter Japan from EU … (leggi tutto)

TORNA INDIETRO